Innovations Series to Educate on Device-Based Therapy for Treatment of Bloodstream Infections

Share Article

DMG Productions explores the latest breakthroughs in hematology.

News Image
Building public awareness of sepsis, and new treatments addressing this growing medical threat are important if we are to curtail its incidence, and improve the clinical outcome of these patients.

— ExThera Medical’s Seraph® Microbind® affinity blood filter will be explored on the award-winning Innovations with Ed, Begley, Jr. television series, which is scheduled to broadcast first quarter of 2018. Check your local listings for more information.

A look at recent advances taking place throughout the medical community will uncover one of the latest breakthroughs in acute care. Focusing on ExThera Medical’s proprietary Seraph® Microbind® Affinity Blood Filter, the show will educate viewers on this first-of-its kind investigational technology, designed to capture and remove a broad range of bacteria, viruses, toxins and pro-inflammatory cytokines from the blood.

“ExThera Medical is focused on developing simple devices for the rapid treatment of life-threatening bloodstream infections, especially in the face of rising incidence rates and the spread of multiple drug-resistant pathogens worldwide,” said Robert Ward, CEO of ExThera Medical. "We are thrilled to be featured on the Innovations series. Building public awareness of sepsis, and new treatments addressing this growing medical threat are important if we are to curtail its incidence, and improve the clinical outcome of these patients.”

“Seraph® is designed to quickly treat blood stream infections to prevent them from becoming life-threatening,” said Michele Nehls, Producer for the series. “Seraph’s very broad-spectrum ability to remove pathogens without harming the treated blood gives it many potential applications.”

# # #

About ExThera Medical
Based in Martinez, California, ExThera Medical is a privately held medical device company developing innovative, single-use blood filters capable of capturing and removing a broad range of bacteria, viruses, parasites, toxins or other harmful substances from whole blood. The company develops therapeutic products to treat patients in the field or hospital, and devices that can purify transfused blood prophylactically. Led by an accomplished management team with extensive experience in blood-contacting devices and biomaterials, the company has a well-protected set of patents and a growing body of data from independent laboratory studies, including testing within DARPA’s Dialysis-Like Therapeutics program. For more information, visit http://www.extheramedical.com.

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.

For more information visit: http://www.InnovationsTelevision.com or call (866) 496-4065.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michele Nehls
DMG Productions
+1 866-496-4065 Ext: 802
Email >
Visit website